Suppr超能文献

口腔白斑病和口腔癌患者的唾液和血清白细胞介素 1β、白细胞介素 6 和肿瘤坏死因子α。

Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer.

机构信息

Department of Oral Medicine, School of Dental Medicine, University of Zagreb, Zagreb, Croatia.

出版信息

Med Oral Patol Oral Cir Bucal. 2012 Jan 1;17(1):e10-5. doi: 10.4317/medoral.17323.

Abstract

OBJECTIVES

The aim of study was to compare salivary and serum concentrations of interleukin 1 beta (IL-1β), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) in patients with oral leukoplakia, oral cancer and healthy controls.

STUDY DESIGN

Eighty eight patients (28 with oral cancer, 29 leukoplakia, and 31 healthy controls) were included in this study. Cytokine concentrations were measured by commercial enzyme linked immunoassay.

RESULTS

Salivary IL-1β and IL-6 were significantly higher in oral cancer patients than in patients with leukoplakia and control group (p<0.05). No differences in concentrations of salivary TNF-α between either of the groups were observed. Serum concentrations of IL-1β were below level of detection in all but two participants. No significant differences between the groups were observed in serum concentrations of IL-6. Serum TNF-α was significantly higher in control subjects than in oral cancer patients.

CONCLUSIONS

Patients with oral cancer have elevated levels of inflammatory cytokines in their saliva. Whether this elevation can be used for monitoring the malignant transformation of oral leukoplakia remains to be answered by further follow up studies.

摘要

目的

本研究旨在比较口腔白斑、口腔癌患者与健康对照者唾液和血清中白细胞介素 1β(IL-1β)、白细胞介素 6(IL-6)和肿瘤坏死因子α(TNF-α)的浓度。

设计

本研究纳入了 88 名患者(28 名口腔癌患者、29 名口腔白斑患者和 31 名健康对照者)。采用商业酶联免疫吸附试验测定细胞因子浓度。

结果

口腔癌患者的唾液 IL-1β 和 IL-6 浓度明显高于口腔白斑患者和对照组(p<0.05)。三组间唾液 TNF-α 浓度无差异。血清中 IL-1β 浓度除了两名参与者外,其余均低于检测水平。三组间血清 IL-6 浓度无显著差异。对照组的血清 TNF-α 浓度明显高于口腔癌患者。

结论

口腔癌患者的唾液中炎症细胞因子水平升高。这种升高是否可用于监测口腔白斑的恶性转化,有待进一步的随访研究来回答。

相似文献

2
Serum and salivary interleukin-1β level in oral precancer: An observational study.
J Cancer Res Ther. 2024 Apr 1;20(3):788-792. doi: 10.4103/jcrt.jcrt_2107_22. Epub 2023 May 2.
3
The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia.
Oral Oncol. 2006 Apr;42(4):370-3. doi: 10.1016/j.oraloncology.2005.09.001. Epub 2005 Dec 1.
4
Salivary levels of IL-1beta, IL-6, IL-8, and TNF-alpha in patients with burning mouth syndrome.
Arch Oral Biol. 2009 Sep;54(9):797-802. doi: 10.1016/j.archoralbio.2009.05.007. Epub 2009 Jun 24.
5
Proinflammatory cytokines in the saliva of patients with active and non-active Crohn's disease.
Pol Arch Med Wewn. 2012;122(5):200-8. doi: 10.20452/pamw.1256. Epub 2012 Apr 24.
6
Salivary and serum interleukin-6 levels in proliferative verrucous leukoplakia.
Clin Oral Investig. 2016 May;20(4):737-43. doi: 10.1007/s00784-015-1551-z. Epub 2015 Aug 9.
7
Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Asian Pac J Cancer Prev. 2019 Jul 1;20(7):2087-2093. doi: 10.31557/APJCP.2019.20.7.2087.
8
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):959-966. doi: 10.1016/j.ijrobp.2016.08.047. Epub 2016 Sep 6.
9
Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis.
J Korean Assoc Oral Maxillofac Surg. 2015 Aug;41(4):171-5. doi: 10.5125/jkaoms.2015.41.4.171. Epub 2015 Aug 21.
10
Changes in plasma steroids and cytokines levels in betel chewing patients in Taiwan.
Steroids. 2016 Jul;111:134-138. doi: 10.1016/j.steroids.2016.03.011. Epub 2016 Mar 23.

引用本文的文献

2
exerts anticancer effects and increase the chemosensitivity of 5-fluorouracil against oral cancer cells .
Bioimpacts. 2024 Aug 3;15:30427. doi: 10.34172/bi.30427. eCollection 2025.
8
Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers.
Clin Transl Oncol. 2025 May;27(5):1887-1920. doi: 10.1007/s12094-024-03742-8. Epub 2024 Oct 8.

本文引用的文献

1
Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva.
Oral Dis. 2008 Nov;14(8):705-12. doi: 10.1111/j.1601-0825.2008.01488.x.
2
Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons.
Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3450-6. doi: 10.1158/1055-9965.EPI-08-0311.
3
Bone remodeling biomarkers of periodontal disease in saliva.
J Periodontol. 2008 Oct;79(10):1913-9. doi: 10.1902/jop.2008.080070.
4
Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management.
Oral Oncol. 2009 Apr-May;45(4-5):317-23. doi: 10.1016/j.oraloncology.2008.05.016. Epub 2008 Jul 31.
6
Comparison of salivary cytokine levels in oral cancer patients and healthy subjects.
Bull Tokyo Dent Coll. 2007 Nov;48(4):199-203. doi: 10.2209/tdcpublication.48.199.
7
Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation.
Cancer Res. 2006 Dec 15;66(24):11565-70. doi: 10.1158/0008-5472.CAN-06-2540.
9
Salivary biomarkers of existing periodontal disease: a cross-sectional study.
J Am Dent Assoc. 2006 Mar;137(3):322-9. doi: 10.14219/jada.archive.2006.0181.
10
Cytokines in head and neck cancer.
Cytokine Growth Factor Rev. 2006 Jun;17(3):141-6. doi: 10.1016/j.cytogfr.2006.02.001. Epub 2006 Mar 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验